Suzanne Lepage

Attention deficit hyperactivity disorder is commonly misunderstood and can reduce the ability of a person to function while impacting their quality of life, said Anjila Arora, director of pharmaceutical benefits at Sun Life Financial Inc., during a session at Benefits Canada’s 2022 Face to Face Drug Plan Management Forum in Toronto in December. Although ADHD […]

  • January 23, 2023 January 17, 2023
  • 07:57

As pharmacists’ scope of practice evolves across the country, their expanded role in drug plan management can improve plan member health and positively impact plan sponsors’ bottom lines. Challenges in the Canadian health-care system — such as the millions of people who don’t have access to a family doctor, extended emergency rooms wait times or […]

  • January 23, 2023 January 17, 2023
  • 07:56

With the cost of drug claims continuing to rise in 2021, benefits plan sponsors can enable certain drug programs to curb costs, keeping their plans sustainable and offering the benefits that members highly value, said Lavina Viegas, director of pharmacy operations at Telus Health, during a session at Benefits Canada’s 2022 Face to Face Drug […]

  • January 23, 2023 January 17, 2023
  • 07:55

While a transplant can be life-altering for a patient as a permanent cure for their underlying condition, it can also profoundly affect their immune system, according to Dr. Matthew Cheng, assistant professor in transplant infectious diseases and medical mycology at McGill University, speaking during a panel discussion at Benefits Canada’s Face to Face Drug Plan […]

  • January 23, 2023 January 17, 2023
  • 07:54

About a million Canadians are impacted by rare diseases, which disproportionately affect younger patients — 70 per cent start in childhood and, sadly, half of these children won’t reach adulthood, said Suzanne Lepage, a private health plan strategist, during a session supported by Alexion Pharmaceuticals at Benefits Canada‘s 2022 Face to Face Drug Plan Management Forum […]

  • January 23, 2023 May 16, 2023
  • 07:54

While vaccine coverage varies across provincial drug plans, several million Canadians who are members of private drug plans don’t have coverage at all, according to Chris Bonnett (pictured left), founder and principal consultant of H3 Consulting, during a panel session supported by GSK, Merck & Co. Inc. and Pfizer Canada Inc. at Benefits Canada’s 2022 […]

  • January 23, 2023 January 20, 2023
  • 07:53

Living with a rare chronic disease while also managing an employer-sponsored benefits plan provides Chris MacLeod with a unique perspective. During a session supported by Vertex Pharmaceuticals at Benefits Canada’s 2022 Face to Face Drug Plan Management Forum in Toronto in December, MacLeod, the founding partner at Cambridge LLP, said he was diagnosed with cystic fibrosis […]

  • January 23, 2023 January 17, 2023
  • 07:52

Approximately three million Canadians live with asthma, a chronic inflammatory disease that affects airways, limits airflow and makes breathing difficult, said Dr. Erika Penz, associate professor in respirology, critical care and sleep medicine at the University of Saskatchewan, during a webinar hosted by Benefits Canada and sponsored by GSK in November. Asthma, which affects people of […]

  • December 22, 2022 December 19, 2022
  • 09:00

Canada has one of the highest incidence rates of inflammatory bowel disease in the world. “We don’t know why, but Canada is one of the hotspots,” said Dr Mark Silverberg, gastroenterologist at Mount Sinai Hospital and the University of Toronto, during a webinar hosted by Benefits Canada and sponsored by Takeda Canada in November. IBD […]

  • November 29, 2022 November 29, 2022
  • 09:00

According to conservative estimates, 100,000 Canadians may suffer from hypertrophic cardiomyopathy with an estimated prevalence of about one in every 200 to 500 individuals, said Dr. Bobby Heydari, a cardiologist and associate professor of medicine at the University of Calgary, during a webinar hosted by Benefits Canada and sponsored by the Bristol-Myers Squibb Co. Patients’ mean […]

  • September 9, 2022 September 9, 2022
  • 09:00